Latigo Biotherapeutics market cap: $1.415 B

Biotechnology: Pharmaceutical Preparations, ranked by market cap

#143Oric PharmaceuticalsORIC$1.47B
#144ArriVent BioPharmaAVBP$1.44B
#145Latigo BiotherapeuticsLTGO$1.41B
#146OmerosOMER$1.39B
#147Jade BiosciencesJBIO$1.36B

Insiders buying

2 open-market purchases by officers and directors of Latigo Biotherapeutics, worth $5.04M. Grants and option exercises are excluded.

Foresite Capital Fund V, L.P., Foresite Capital Fund VI LP, Foresite Capital Management V, LLC, Foresite Capital Management VI LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Opportunity Management V, LLC$2.52M
140,000 shares at $18.00 on 10 Aug 2026 · filed 10 Aug 2026
James B. Tananbaum$2.52M
140,000 shares at $18.00 on 10 Aug 2026 · filed 10 Aug 2026

Where these numbers come from

Share counts and financials for Latigo Biotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 21 Aug 2026. Read the methodology.